Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07726940) titled 'Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS' on July 21.

Study Type: Observational [Patient Registry]

Primary Sponsor: Southeast University, China

Condition: Acute Respiratory Distress Syndrome (ARDS)

Recruitment Status: Recruiting

Date of First Enrollment: June 16, 2026

Target Sample Size: 1776

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07726940

Published by HT Digital Content Services with permission from Health Daily Digest....